Background/Aims: Some previous studies have reported that hysterectomy predicts increased prevalence of cardiovascular diseases, but the findings are disputed. We aimed to examine associations between hysterectomy and cardiovascular disease in a Norwegian cross-sectional health study. Methods: The data were obtained from the population-based cross-sectional Nord-Trøndelag Health Study (The HUNT-2 Study). Of 46,709 invited females, 35,280 (76%) participated; 939 (3%) reported hysterectomy without oophorectomy (exposed women). Each exposed woman was age-matched with four randomly chosen women (n = 3,756) without hysterectomy or oophorectomy. Oophorectomy and hysterectomy status was self-reported by the women. Hazard ratio for cardiovascular diseases was calculated by Cox regression analyses with hysterectomy as a time-dependent covariate. Results: Median time since hysterectomy was 14 years (range 0–56 years). We calculated a significantly larger cumulative probability of cardiovascular diseases after hysterectomy with a hazard ratio of 1.92, 95% CI (1.51–2.38) after adjustments for cardiovascular risk factors (diabetes, age, use of hormonal replacement therapy and positive family history of myocardial infarction). Conclusion: Women had a significantly increased risk of cardiovascular diseases after hysterectomy compared to age-matched controls. Studies with longitudinal design and confirmed medical outcome data are needed.

1.
Jacobs AK: Women, ischemic heart disease, revascularization, and the gender gap: what are we missing? J Am Coll Cardiol 2006;47(3 suppl):S63–S65.
2.
Polk DM, Naqvi TZ: Cardiovascular disease in women: sex differences in presentation, risk factors, and evaluation. Curr Cardiol Rep 2005;7:166–172.
3.
Kafy S, Al-Sannan B, Kabli N, Tulandi T: Patient satisfaction after laparoscopic total or supracervical hysterectomy. Gynecol Obstet Invest 2009;67:169–172.
4.
Falcone T, Walters MD: Hysterectomy for benign disease. Obstet Gynecol 2008;111:753–767.
5.
Kjerulff KH, Langenberg PW, Rhodes JC, Harvey LA, Guzinski GM, Stolley PD: Effectiveness of hysterectomy. Obstet Gynecol 2000;95:319–326.
6.
Kuppermann M, Varner RE, Summitt RL Jr, Learman LA, Ireland C, Vittinghoff E, et al: Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA 2004;291:1447–1455.
7.
Howard BV, Kuller L, Langer R, Manson JE, Allen C, Assaf A, et al: Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women’s Health Initiative Observational Study. Circulation 2005;111:1462–1470.
8.
Merrill RM: Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 2008;14:CR24–CR31.
9.
Backe B, Lilleeng S: Hysterectomy in Norway. Quality of data and clinical practice (in Norwegian). Tidsskr Nor Laegeforen 1993;113:971–974.
10.
van der Schouw YT, van der GY, Steyerberg EW, Eijkemans JC, Banga JD: Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996;347:714–718.
11.
Hsia J, Barad D, Margolis K, Rodabough R, McGovern PG, Limacher MC, et al: Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (The Women’s Health Initiative). Am J Cardiol 2003;92:264–269.
12.
Farquhar CM, Sadler L, Harvey SA, Stewart AW: The association of hysterectomy and menopause: a prospective cohort study. BJOG 2005;112:956–962.
13.
Holmen J, Midthjell K, Kruger Ø, Langhammer A, Homen TL, Bratberg GH, et al: The Nord-Trøndelag Health Study 1995–97 (HUNT 2): Objectives, contents, methods and participation. Nor J Epidemiol 2003;13:19–32.
14.
Thorsen L, Nystad W, Stigum H, Dahl O, Klepp O, Bremnes RM, et al: The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Support Care Cancer 2005;13:637–646.
15.
Krokstad S, Westin S: Health inequalities by socioeconomic status among men in the Nord-Trondelag Health Study, Norway. Scand J Public Health 2002;30:113–124.
16.
Nakagawa S, Cuthill IC: Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc 2007;82:591–605.
17.
Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Lawrence Erlabaum Associates, 1988.
18.
Andersen PK: Time-Dependent Covariate. Encyclopedia of Biostatistics. New York, Wiley & Sons, 2005.
19.
Treasure FP: Counting processes. University of Cambridge, 1993. www.statslab.cam.ac.uk/~lab/Treasure/counting_Processes.pdf.
20.
Andersen PK, Borgan Ø, Gill RD: Statistical Models Based on Counting Processes. New York, Springer, 1993.
21.
Brett KM, Marsh JV, Madans JH: Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample. J Womens Health 1997;6:309–316.
22.
Meilahn EN, Matthews KA, Egeland G, Kelsey SF: Characteristics of women with hysterectomy. Maturitas 1989;11:319–329.
23.
Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, et al: Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet Gynecol 2009;113:1027–1037.
24.
Ingelsson E, Lundholm C, Johansson AL, Altman D: Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J 2011;32:745–750.
25.
Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R: A prospective study of hypertension and risk of uterine leiomyomata. Am J Epidemiol 2005;161:628–638.
26.
Settnes A, Jorgensen T: Hypertension and hysterectomy in Danish women. Obstet Gynecol 1998;92:274–280.
27.
Silver MA, Raghuvir R, Fedirko B, Elser D: Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling. J Clin Hypertens (Greenwich) 2005;7:664–668.
28.
Mendelsohn ME, Karas RH: Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583–1587.
29.
Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH: Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105–1110.
30.
Brett KM, Madans JH: Hysterectomy use: the correspondence between self-reports and hospital records. Am J Public Health 1994;84:1653–1655.
31.
Irwin KL, Wingo PA, Lee NC: Agreement of self-reported ovarian number following gynecologic surgery with medical record reports. J Clin Epidemiol 1990;43:181–187.
32.
Mayou R, Bryant B, Forfar C, Clark D: Non-cardiac chest pain and benign palpitations in the cardiac clinic. Br Heart J 1994;72:548–553.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.